TANDEM TRIAL: a factorial randomised controlled trial of dose and review schedule of bevacizumab (Avastin) for neovascular macular degeneration in the East Midlands

por Foss, Alexander, Haydock, Rebecca, Childs, Margaret, Duley, Lelia M, Empeslidis, Theo, Dhar-Munshi, Sushma, Montgomery, Alan A, Ogollah, Reuben, Ozolins, Mara, Tesha, Paul, Mitchell, Eleanor
Publicado 2020

Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial

por Foss, Alexander JE, Childs, Margaret, Reeves, Barnaby C, Empeslidis, Theo, Tesha, Paul, Dhar-Munshi, Sushma, Mughal, Samah, Culliford, Lucy, Rogers, Chris A, Tan, Wei, Montgomery, Alan
Publicado 2015